- What we do
Developing and manufacturing life-saving products
We are the first and only manufacturers of Erwinase® (Crisantaspase [DN add]) an asparginase enzyme indicated for the treatment of Acute Lymphoblastic Leukaemia and of the UK’s licensed anthrax vaccine.
Porton Biopharma is the sole manufacturer of Erwinase® (Crisantaspase) used in the treatment of Acute Lymphoblastic Leukaemia which is distributed and marketed on a world-wide basis by Clinigen Inc. The product is manufactured in our licensed cGMP pharmaceutical manufacturing facilities.Read more
Porton Biopharma is the sole manufacturer of the UK’s licensed anthrax vaccine. The vaccine is manufactured for, and on behalf of, the UK Government. It is supplied for both occupational health purposes and to protect those at risk from the use of anthrax as a biological weapon.Read more